Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
So far the only demonstrable advantage to fundholders has been a reduction in prescribing costs.2,3 This is an eccentric achievement in a country whose prescribing costs historically have been among the lowest in western Europe.4 It tells us nothing about either the quality of care, which may decline as costs are cut, or the long term economic costs of short term savings on prescribing, which may be appreciable.5
The economic costs of fundholding are considerable and include both open costs (such as management fees, subsidies for computerisation, and the administrative costs of billing and reviewing contracts) and hidden costs (such as costs for staff in family health services authorities, hospitals, and the Audit Commission). The political
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
StumbleUpon
Technorati What's this?